- Home
- SMSI vs SLGL Comparison
SMSI vs SLGL Comparison
Compare SMSI & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- SLGL
- Stock Information
- Founded
- SMSI 1982
- SLGL 1997
- Country
- SMSI United States
- SLGL Israel
- Employees
- SMSI N/A
- SLGL N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- SLGL Health Care
- Exchange
- SMSI Nasdaq
- SLGL Nasdaq
- Market Cap
- SMSI 16.7M
- SLGL 19.3M
- IPO Year
- SMSI 1995
- SLGL 2018
- Fundamental
- Price
- SMSI $0.89
- SLGL $8.02
- Analyst Decision
- SMSI Strong Buy
- SLGL Buy
- Analyst Count
- SMSI 1
- SLGL 1
- Target Price
- SMSI $5.00
- SLGL $40.00
- AVG Volume (30 Days)
- SMSI 293.0K
- SLGL 6.4K
- Earning Date
- SMSI 07-31-2025
- SLGL 08-15-2025
- Dividend Yield
- SMSI N/A
- SLGL N/A
- EPS Growth
- SMSI N/A
- SLGL N/A
- EPS
- SMSI N/A
- SLGL N/A
- Revenue
- SMSI $19,378,000.00
- SLGL $12,103,000.00
- Revenue This Year
- SMSI $10.12
- SLGL N/A
- Revenue Next Year
- SMSI $63.12
- SLGL $31.17
- P/E Ratio
- SMSI N/A
- SLGL N/A
- Revenue Growth
- SMSI N/A
- SLGL 603.66
- 52 Week Low
- SMSI $0.52
- SLGL $3.34
- 52 Week High
- SMSI $2.57
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- SMSI 47.81
- SLGL 58.29
- Support Level
- SMSI $0.87
- SLGL $7.62
- Resistance Level
- SMSI $1.30
- SLGL $8.49
- Average True Range (ATR)
- SMSI 0.10
- SLGL 0.33
- MACD
- SMSI 0.00
- SLGL 0.08
- Stochastic Oscillator
- SMSI 20.94
- SLGL 61.88
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.